As you have probably already heard, in September 2013 the FH Foundation held the first-ever global Familial Hypercholesterolemia (FH) Summit. Chairs of the inaugural event were Dr. Muin Khoury (Centers for Disease Control and Prevention) and Dr. Dan Rader (University of Pennsylvania).
Dr. Khoury regularly contributes to the CDC blog with articles from a public health perspective. In this particular post he explains how the FH Summit brought together key stakeholders in addressing Familial Hypercholesterolemia as a public health concern that requires urgent action in the medical community, government, and research circles. The prevalence of Familial Hypercholesterolemia points to a need for cascade screening (systematic testing of family members of individuals who have been diagnosed with FH). Among the priorities at the Summit were working towards a unified set of criteria for the diagnosis of FH (lack of diagnosis is currently a big problem in the US), reviewing the success of FH cascade screening programs in other countries (Spain, Netherlands, Wales), and launching the only active Familial Hypercholesterolemia Patient Registry in the United States (CASCADE FH™). To find out more about the importance of Familial Hypercholesterolemia in the Public Health sector and how the CDC are addressing gaps in FH care, read the full article here.